Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
JXMClass II

Enzyme Immunoassay, Benzodiazepine

21 CFR 862.3170 / Clinical Toxicology

JXM is the FDA product code for Enzyme Immunoassay, Benzodiazepine, a class II device type, regulated under 21 CFR 862.3170. As of , FDA records hold 90 510(k) clearances under this code, the most recent dated , and 81 recalls.

Classification record

Product code
JXM
Device name
Enzyme Immunoassay, Benzodiazepine
Regulation
21 CFR 862.3170
Device class
Class II
Review panel
Clinical Toxicology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
Yes
Ingested clearances
90
Ingested recalls
81

Clearances, product code JXM

By decision year
90 clearances under product code JXM with a decision year between 1979 and 2024, 1995 the highest year at 7.
Show the numbers
510(k) clearances under FDA product code JXM by decision year
YearClearances
19791
19801
19811
19844
19851
19861
19876
19883
19893
19902
19913
19922
19934
19943
19957
19964
19971
19986
19993
20005
20015
20023
20031
20041
20054
20062
20101
20111
20121
20152
20162
20172
20181
20191
20221
20241

Applicants with the most clearances

Product code JXM

Companies listing this code with FDA

Companies whose registered establishments list this code

12 of 77 companies shown, in name order